Table 5.
Cox proportional hazards models of osteoporotic fracture risk for older, long-term survivors of early-stage breast cancer exposed to tamoxifen versus survivors not exposed to tamoxifen.
All fractures | Hip and wrist fractures |
|||
---|---|---|---|---|
Covariates | HR* | 95% CI | HR* | 95% CI |
Model 1: Study site, age | 0.9 | 0.7, 1.3 | 0.9 | 0.7, 1.3 |
Model 2: Study site, age, race, body mass index |
0.9 | 0.7, 1.2 | 0.9 | 0.7, 1.3 |
Model 3: Study site, age, tumor and treatment variables |
0.9 | 0.6, 1.2 | 0.9 | 0.6, 1.3 |
Model 4: Study site, age, smoking status, comorbid conditions |
1.0 | 0.7, 1.3 | 1.0 | 0.7, 1.4 |
Model 5: Study site, age, drug exposure** |
0.9 | 0.6, 1.2 | 0.9 | 0.6, 1.3 |
Model 6: All covariates: Study site, age, race, body mass index, tumor and treatment variables, smoking status, comorbid conditions, and drug exposure |
0.9 | 0.6, 1.2 | 0.9 | 0.6, 1.4 |
HR = hazard ratio.
Drug exposure detail in Supplemental Table 1